CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Sees Significant Decline in Short Interest

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) was the target of a significant drop in short interest in February. As of February 13th, there was short interest totaling 2,966 shares, a drop of 24.8% from the January 29th total of 3,944 shares. Based on an average daily volume of 6,547 shares, the short-interest ratio is currently 0.5 days. Based on an average daily volume of 6,547 shares, the short-interest ratio is currently 0.5 days.

CSPC Pharmaceutical Group Trading Up 3.5%

CSPCY opened at C$4.97 on Monday. The stock has a 50-day moving average price of C$4.87 and a 200-day moving average price of C$4.67. CSPC Pharmaceutical Group has a 12-month low of C$2.31 and a 12-month high of C$5.83.

CSPC Pharmaceutical Group Company Profile

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.

The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.